prednisone has been researched along with T-Cell Lymphoma in 204 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to determine the maximum tolerated dose (MTD) and safety of the combination of bortezomib and cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) as first-line therapy in advanced, aggressive T-cell lymphoma." | 9.13 | Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma. ( Eom, HS; Huh, J; Kang, HJ; Kim, K; Kim, WS; Ko, YH; Lee, J; Park, K; Ryoo, BY; Suh, C, 2008) |
| "Enteropathy-type intestinal T-cell lymphoma (ETCL) is a highly aggressive disease with poor response to conventional CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) chemotherapy." | 9.11 | Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. ( Chott, A; Drach, J; Hejna, M; Hoffmann, M; Püspök, A; Raderer, M; Wöhrer, S, 2004) |
| "To describe the clinical course of patients with angioimmunoblastic lymphadenopathy (AILD)-type lymphoma with a sequential treatment with prednisone and COPBLAM/IMVP-16." | 9.07 | Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. ( Agthe, A; Brittinger, G; Engelhard, M; Griesser, H; Huhn, D; Kuse, R; Lennert, K; Schwerdtfeger, R; Siegert, W; Tiemann, M, 1992) |
| "Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle." | 7.81 | Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015) |
| "Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare condition that falls underneath the umbrella of primary cutaneous T-cell lymphomas (CTCLs)." | 5.48 | Subcutaneous panniculitis-like T-cell lymphoma responsive to combination therapy with methotrexate and corticosteroids. ( Cascio, MJ; Fett, N; Grinich, E; Koon, SM, 2018) |
| "Lenalidomide was well tolerated without side-effects." | 5.39 | Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomide. ( Beckers, MM; Huls, G, 2013) |
| "The aim of the study was to determine the maximum tolerated dose (MTD) and safety of the combination of bortezomib and cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) as first-line therapy in advanced, aggressive T-cell lymphoma." | 5.13 | Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma. ( Eom, HS; Huh, J; Kang, HJ; Kim, K; Kim, WS; Ko, YH; Lee, J; Park, K; Ryoo, BY; Suh, C, 2008) |
| "Enteropathy-type intestinal T-cell lymphoma (ETCL) is a highly aggressive disease with poor response to conventional CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) chemotherapy." | 5.11 | Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. ( Chott, A; Drach, J; Hejna, M; Hoffmann, M; Püspök, A; Raderer, M; Wöhrer, S, 2004) |
| "To describe the clinical course of patients with angioimmunoblastic lymphadenopathy (AILD)-type lymphoma with a sequential treatment with prednisone and COPBLAM/IMVP-16." | 5.07 | Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. ( Agthe, A; Brittinger, G; Engelhard, M; Griesser, H; Huhn, D; Kuse, R; Lennert, K; Schwerdtfeger, R; Siegert, W; Tiemann, M, 1992) |
| "Patients with angioimmunoblastic T-cell lymphoma (AITL) are treated with cyclophosphamide, doxorubicin, vincristine and prednisone with or without etoposide (CHO(E)P)." | 4.12 | Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis. ( Böhmer, L; Brink, M; Diepstra, A; Huls, GA; Jansen, PM; Kersten, MJ; Meeuwes, FO; Mutsaers, PGNJ; Nijland, M; Oostvogels, R; Plattel, WJ; Snijders, TJF; van der Poel, MWM; Vermaat, JSP; Visser, O; Woei-A-Jin, S; Wondergem, M, 2022) |
| "Anthracycline-containing regimens, namely cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) or CHOEP (CHOP + etoposide), represent the current standard of care for patients with newly diagnosed peripheral T-cell lymphomas (PTCLs), although responses are unsatisfactory." | 3.91 | Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma. ( Biancon, G; Carniti, C; Cavanè, A; Corradini, P; Dugo, M; Magni, M; Paolizzi, C; Rizzitano, S, 2019) |
| "Determine the frequency and prognostic value of circulating Epstein-Barr virus (EBV) DNA copy number in angioimmunoblastic T-cell lymphoma (AITL) patients who were treated with dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (DA-EPOCH) regimens." | 3.91 | The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH. ( Fan, L; Li, JY; Li, W; Liang, JH; Lu, L; Xu, W; Zhu, HY, 2019) |
| "There is a pressing need for more effective therapies to treat patients with T-cell lymphomas (TCLs), including first-line approaches that increase the response rate to cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP) chemotherapy." | 3.91 | Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas. ( Brem, EA; Christie, AL; Cidado, J; Crombie, JL; Drew, L; Koch, R; Letai, A; Morrow, SN; Palmer, AC; Plana, D; Schuller, AG; Secrist, JP; Shigemori, K; Van Scoyk, A; Weinstock, DM; Wu, W, 2019) |
| "Retrospective case study of 31 dogs with naïve T-cell lymphoma treated with a lomustine (CCNU), vincristine, procarbazine and prednisolone (LOPP) protocol." | 3.88 | LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma. ( Brown, PM; Langova, V; Nguyen, S; Tzannes, S; White, J, 2018) |
| " Results of axillary lymph node, skin, and bone-marrow biopsies led to the diagnosis of angioimmunoblastic T-cell lymphoma (AITL), for which CEPP therapy (cyclophosphamide, etoposide, procarbazine, and prednisolone) was initiated." | 3.88 | Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma. ( Hiroshima, Y; Joshita, S; Kawata, K; Kimura, T; Kobayashi, H; Mori, H; Tanaka, E; Tanaka, N; Umemura, T; Wada, S; Wakabayashi, SI, 2018) |
| "Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle." | 3.81 | Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. ( Back, AR; Lee, J; Phillips, JC; Schleis, SE; Smith, AN; Smrkovski, OA, 2015) |
| "Six courses of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) or cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone (CHOEP) chemotherapy were recommended for first-line therapy of patients with nodal, intestinal or hepatosplenic T-cell lymphomas (evidence: low; recommendation: do, weak)." | 3.80 | SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias. ( Barosi, G; Billio, A; Corradini, P; Gallamini, A; Marchetti, M; Pileri, S; Pimpinelli, N; Rossi, G; Tura, S; Zinzani, PL, 2014) |
| "Dogs with multicentric T-cell lymphoma are commonly treated with CHOP chemotherapy protocols that include cyclophosphamide, doxorubicin, vincristine and prednisone." | 3.77 | CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma. ( Borrofka, SA; Frazier, S; Kent, MS; Rebhun, RB; Rodriguez, CO; Skorupski, K, 2011) |
| "The present study aimed to analyse the treatment outcome of IMVP-16/Pd (ifosfamide, methotrexate, etoposide and prednisone) followed by high-dose chemotherapy and autologous stem cell transplantation (HDC/ASCT) for patients with peripheral T-cell lymphomas (PTCLs) who were previously treated with CHOP." | 3.73 | IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas. ( Im, YH; Jung, CW; Kang, JH; Kang, WK; Kim, K; Kim, WS; Ko, YH; Lee, J; Lee, MH; Lee, SH; Park, BB; Park, JO; Park, K; Park, KW; Park, YS, 2005) |
| "The shocking fact was that re-biopsy of lymphadenopathy revealed peripheral T-cell lymphoma (PTCL) and angioimmunoblastic T-cell lymphoma (AITL)." | 3.01 | Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review. ( Chen, B; Chen, P; Huang, F; Jin, X; Li, J; Liang, Y; Liu, H; Xiao, X; Yuan, X, 2023) |
| "LDE-carmustine was shown to be safe and effective in a drug combination protocol, which encourages larger studies to investigate the use of this novel formulation to treat canine lymphomas." | 2.80 | Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma. ( Barboza, R; Coelho, BM; Guerra, JL; Lucas, SR; Maranhão, RC; Pozzi, DH, 2015) |
| "Of these patients, 22 (40%) had Burkitt's lymphoma (BKL), 22 (40%) had diffuse large B-cell lymphoma (DLBL) and 11 (20%) had anaplastic large T-cell lymphoma (ALCL)." | 2.72 | Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol. ( Guan, ZZ; He, YJ; Lin, JY; Lui, DG; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ, 2006) |
| "CHOP-14 with the addition of rhG-CSF is safe and practicable in a large multicentre setting in patients aged 18-75 years." | 2.71 | Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). ( Bittner, S; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rudolph, C; Schmalenberg, H; Schmits, R; Truemper, L; Wunderlich, A, 2003) |
| "Bexarotene is a newly registered drug." | 2.42 | [Standard and experimental therapy of cutaneous T-cell lymphoma]. ( Beyeler, M; Dummer, R, 2003) |
| "Reversible posterior leukoencephalopathy syndrome is a newly characterised and increasingly recognized clinico-radiologic syndrome." | 2.41 | [Reversible posterior leukoencephalopathy in a patient with non-Hodgkin's lymphoma after treatment with CHOP]. ( Berbel García, A; Cedena Romero, T; Giménez-Mesa, E; Martínez-Salio, A; Porta-Etessam, J; Salama Bendoyan, P, 2001) |
| "While both are rare, lupus erythematosus panniculitis of the orbit is even more exceptional; this patient's indolent, chronic relapsing course distinguished itself from the typical aggression of orbital T-cell lymphoma." | 1.48 | Orbital T-cell lymphoma versus lupus panniculitits: a T-cell-mediated spectrum of orbital lymphoproliferative disease. ( Huggins, AB; Kim, C; Rabinowitz, MP, 2018) |
| "Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare condition that falls underneath the umbrella of primary cutaneous T-cell lymphomas (CTCLs)." | 1.48 | Subcutaneous panniculitis-like T-cell lymphoma responsive to combination therapy with methotrexate and corticosteroids. ( Cascio, MJ; Fett, N; Grinich, E; Koon, SM, 2018) |
| "Subcutaneous Panniculitis-like T-cell lymphoma (SPTCL) is a rare subtype of childhood non-Hodgkin lymphoma." | 1.39 | Subcutaneous Panniculitis-like T-cell lymphoma in two pediatric patients: an HIV-positive adolescent and a 4-month-old infant. ( Acree, SC; Cassarino, DS; Church, JA; Gaynon, PS; Pattengale, PK; Tovar, JP; Wang, LL, 2013) |
| "Lenalidomide was well tolerated without side-effects." | 1.39 | Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomide. ( Beckers, MM; Huls, G, 2013) |
| "The authors present the report of an ankylosing spondylitis combined with angioimmunoblastic T cell lymphoma after the anti-tumour necrosis factor treatment." | 1.37 | Ankylosing spondylitis combined with angioimmunoblastic T cell lymphoma. ( Xu, L, 2011) |
| "Trisomy 21 is a chromosomal abnormality associated with a risk of malignancy that differs from their normal counterparts." | 1.36 | Subcutaneous panniculitis-like T-cell lymphoma in a child with trisomy 21. ( Barbosa, J; Drach, L; Mixon, B; Monforte, H, 2010) |
| "We report on a patient with Pneumocystis jirovecii pneumonia who developed fever, rash, eosinophilia and hepatitis 10 days after initiation of a therapy with sulfamethoxazole and trimethoprim." | 1.36 | [Rash, fever, eosinophilia and elevated liver enzymes. DRESS syndrome (drug reaction or rash with eosinophilia and systemic symptoms)]. ( Derungs, A; Kummer, O; Rätz Bravo, AE, 2010) |
| "In January 2006 after severe recurrences of panuveitis a diagnostic vitrectomy was performed." | 1.35 | Ocular involvement in nasal natural killer T-cell lymphoma. ( Asioli, S; Cappuccini, L; Chan, CC; Cimino, L; Ilariucci, F; Masetti, M; Masini, L; Sartori, A; Shen, D, 2009) |
| "The treatment with prednisone (1 mg/kg) brought the rapid improvement of muscle weakness and CPK value as well as mouth dryness and cholestatic liver dysfunction like in primary biliary cirrhosis." | 1.35 | [A case of chronic graft-versus-host disease presenting with polymyositis]. ( Inoue, M; Kitazono, T; Maeda, A; Okazaki, T; Ozaki, S; Shibata, T, 2009) |
| "The diagnosis of mixed-type autoimmune haemolytic anaemia (AIHA) is based on demonstrating the presence of "warm" IgG auto-antibody and "low titre" ( < 64 at 4 degrees C), "high thermal amplitude" (reacting at or >30 degrees C) "cold" IgM auto-antibody." | 1.34 | Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma. ( Keevil, VL; Lakhani, A; Needs, M; Tiwari, D; Win, N, 2007) |
| "Local relapse was observed to be higher in the chemotherapy alone group compared to the chemoradiotherapy group." | 1.33 | Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract. ( Choi, CW; Jung, KY; Kim, BS; Kim, CY; Kim, IS; Kim, JS; Kim, SJ; Seo, HY; Seol, HR; Sung, HJ, 2006) |
| "Two patients presented with anasarca, fevers and sweats." | 1.31 | Non-Hodgkin's lymphoma presenting as anasarca: probably mediated by tumor necrosis factor alpha (TNF-alpha). ( Burgess, R; Day, DS; Jillella, AP; Kallab, AM; Severson, K, 2000) |
| "We report two patients who developed visual hallucinations during treatment with vincristine." | 1.29 | Visual hallucinations following treatment with vincristine. ( Chapman, CS; Ghosh, K; Murphy, P; Sivakumaran, M; Wood, JK, 1994) |
| "Hematuria is the most common symptom in bladder lymphoma, outlet obstruction in prostate lymphoma." | 1.29 | [Non-Hodgkin's lymphoma with primary localization in the bladder and prostate region. Description of a case]. ( Gallmetzer, J; Mahlknecht, A, 1995) |
| " When the glucocorticoid dosage was reduced or the drug discontinued, the nephrotic syndrome recurred." | 1.29 | [T-cell lymphoma under immunosuppressive treatment in minimal change glomerulopathy with nephrotic syndrome]. ( Schollmeyer, P; Späth, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 30 (14.71) | 18.2507 |
| 2000's | 95 (46.57) | 29.6817 |
| 2010's | 72 (35.29) | 24.3611 |
| 2020's | 7 (3.43) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, MC | 1 |
| Musuraca, G | 1 |
| Battistini, R | 1 |
| Casaroli, I | 1 |
| Zoli, V | 1 |
| Anticoli-Borza, P | 1 |
| Arcari, A | 1 |
| Naso, V | 1 |
| di Landro, F | 1 |
| Fabbri, F | 1 |
| Tafuri, A | 1 |
| Bocci, G | 1 |
| Merli, F | 1 |
| Meeuwes, FO | 1 |
| Brink, M | 1 |
| van der Poel, MWM | 1 |
| Kersten, MJ | 1 |
| Wondergem, M | 1 |
| Mutsaers, PGNJ | 1 |
| Böhmer, L | 1 |
| Woei-A-Jin, S | 1 |
| Visser, O | 1 |
| Oostvogels, R | 1 |
| Jansen, PM | 1 |
| Diepstra, A | 1 |
| Snijders, TJF | 1 |
| Plattel, WJ | 1 |
| Huls, GA | 1 |
| Vermaat, JSP | 1 |
| Nijland, M | 1 |
| Du, J | 1 |
| Qiu, C | 1 |
| Li, WS | 1 |
| Wang, B | 3 |
| Han, XL | 1 |
| Lin, SW | 1 |
| Fu, XH | 1 |
| Hou, J | 1 |
| Huang, ZF | 1 |
| Lenz, JA | 1 |
| Benjamin, SE | 1 |
| Walsh, KA | 1 |
| Keuler, NS | 1 |
| Atherton, MJ | 1 |
| Jin, X | 1 |
| Liu, H | 1 |
| Li, J | 6 |
| Xiao, X | 1 |
| Yuan, X | 1 |
| Chen, P | 1 |
| Chen, B | 1 |
| Liang, Y | 1 |
| Huang, F | 1 |
| Magni, M | 1 |
| Biancon, G | 1 |
| Rizzitano, S | 1 |
| Cavanè, A | 1 |
| Paolizzi, C | 1 |
| Dugo, M | 1 |
| Corradini, P | 2 |
| Carniti, C | 1 |
| Poon, F | 1 |
| Ieremia, E | 1 |
| Collins, G | 1 |
| Matin, RN | 1 |
| Matsuyama, A | 1 |
| Bienzle, D | 1 |
| Richardson, D | 1 |
| Deravi, N | 1 |
| Hwang, MH | 1 |
| Darzentas, N | 1 |
| Keller, SM | 2 |
| Craig, KKL | 1 |
| Wood, GA | 1 |
| Mutsaers, AJ | 1 |
| Wood, RD | 1 |
| Dhir, A | 1 |
| Hill, B | 1 |
| Waite, ES | 1 |
| Cairo, MS | 1 |
| Xavier, AC | 1 |
| Schmitz, C | 1 |
| Rekowski, J | 1 |
| Müller, SP | 1 |
| Farsijani, N | 1 |
| Hertenstein, B | 1 |
| Franzius, C | 1 |
| von Verschuer, U | 1 |
| La Rosée, P | 1 |
| Freesmeyer, M | 1 |
| Wilop, S | 1 |
| Krohn, T | 1 |
| Raghavachar, A | 1 |
| Ganser, A | 1 |
| Bengel, FM | 1 |
| Prange-Krex, G | 1 |
| Kroschinsky, F | 1 |
| Kotzerke, J | 1 |
| Giagounidis, A | 1 |
| Dührsen, U | 1 |
| Hüttmann, A | 1 |
| Xiong, Y | 1 |
| Yang, L | 1 |
| Dai, J | 1 |
| Zhou, F | 1 |
| Zhou, Y | 1 |
| Broccoli, A | 2 |
| Zinzani, PL | 3 |
| Brown, PM | 1 |
| Tzannes, S | 1 |
| Nguyen, S | 1 |
| White, J | 1 |
| Langova, V | 1 |
| Sindhu, H | 1 |
| Chen, R | 1 |
| Chen, H | 1 |
| Wong, J | 1 |
| Chaudhry, R | 1 |
| Xu, Y | 1 |
| Wang, JC | 1 |
| Song, M | 1 |
| Kim, JY | 1 |
| Choi, JS | 1 |
| Yoon, B | 1 |
| Kim, M | 1 |
| Kim, SJ | 3 |
| Kim, SY | 1 |
| Huggins, AB | 1 |
| Kim, C | 1 |
| Rabinowitz, MP | 1 |
| Cornish, N | 1 |
| Maybury, B | 1 |
| Otton, S | 1 |
| Lee, T | 1 |
| Park, BG | 1 |
| You, E | 1 |
| Cho, YU | 1 |
| Jang, S | 1 |
| Lee, SM | 1 |
| Suh, C | 2 |
| Park, CJ | 1 |
| Wakabayashi, SI | 1 |
| Kimura, T | 1 |
| Tanaka, N | 1 |
| Joshita, S | 1 |
| Kawata, K | 1 |
| Umemura, T | 1 |
| Hiroshima, Y | 1 |
| Mori, H | 1 |
| Kobayashi, H | 2 |
| Wada, S | 1 |
| Tanaka, E | 1 |
| Liang, JH | 1 |
| Lu, L | 1 |
| Zhu, HY | 1 |
| Li, W | 1 |
| Fan, L | 1 |
| Li, JY | 1 |
| Xu, W | 1 |
| Alkatan, HM | 1 |
| Alrashed, SH | 1 |
| Al-Rikabi, AC | 1 |
| Al-Faky, YH | 1 |
| Umakanathan, M | 1 |
| P'ng, CH | 1 |
| Varikatt, W | 1 |
| Kwok, F | 1 |
| Lin, MW | 1 |
| Vucak-Dzumhur, M | 1 |
| DeWeerdt, S | 1 |
| Koch, R | 1 |
| Christie, AL | 1 |
| Crombie, JL | 1 |
| Palmer, AC | 1 |
| Plana, D | 1 |
| Shigemori, K | 1 |
| Morrow, SN | 1 |
| Van Scoyk, A | 1 |
| Wu, W | 1 |
| Brem, EA | 1 |
| Secrist, JP | 1 |
| Drew, L | 1 |
| Schuller, AG | 1 |
| Cidado, J | 1 |
| Letai, A | 1 |
| Weinstock, DM | 1 |
| Dyagil, IS | 1 |
| Sholoyko, VV | 1 |
| Silayev, YO | 1 |
| Martina, ZV | 1 |
| Dmytrenko, IV | 1 |
| Tovstogan, AO | 1 |
| Fedorenko, VG | 1 |
| Shlyakhtychenko, TY | 1 |
| Minchenko, ZM | 1 |
| Grinich, E | 1 |
| Koon, SM | 1 |
| Cascio, MJ | 1 |
| Fett, N | 1 |
| Phillips, EH | 1 |
| Devereux, S | 1 |
| Radford, J | 1 |
| Mir, N | 1 |
| Adedayo, T | 1 |
| Clifton-Hadley, L | 1 |
| Johnson, R | 1 |
| Tobiasson, M | 1 |
| Pandzic, T | 1 |
| Cavelier, L | 1 |
| Sander, B | 1 |
| Wahlin, BE | 1 |
| Xiao, Y | 1 |
| Zhu, F | 1 |
| Liu, T | 1 |
| Li, Q | 1 |
| Li, X | 1 |
| Wu, G | 1 |
| Zhang, L | 2 |
| Kamata, M | 1 |
| Sugaya, M | 2 |
| Miyagaki, T | 1 |
| Sonoda, K | 1 |
| Ichimura, Y | 1 |
| Mitsui, H | 1 |
| Sato, S | 1 |
| Kamikubo, Y | 1 |
| Kurokawa, M | 1 |
| Mishra, S | 1 |
| Shukla, A | 1 |
| Tripathi, AK | 1 |
| Kumar, A | 1 |
| Lucas, SR | 1 |
| Maranhão, RC | 1 |
| Guerra, JL | 1 |
| Coelho, BM | 1 |
| Barboza, R | 1 |
| Pozzi, DH | 1 |
| Lee, E | 1 |
| Kim, TM | 1 |
| Lim, Y | 1 |
| Jeon, YK | 1 |
| Go, H | 1 |
| Kim, CW | 1 |
| Heo, DS | 1 |
| Faria, E | 1 |
| Turturro, F | 1 |
| Rao, P | 1 |
| Matin, SF | 1 |
| Sekiguchi, Y | 1 |
| Matsuzawa, N | 1 |
| Shimada, A | 1 |
| Imai, H | 1 |
| Wakabayashi, M | 1 |
| Sugimoto, K | 1 |
| Nakamura, N | 1 |
| Sawada, T | 1 |
| Izutsu, K | 1 |
| Takeuchi, K | 1 |
| Ohta, Y | 1 |
| Komatsu, N | 1 |
| Noguchi, M | 1 |
| Back, AR | 1 |
| Schleis, SE | 1 |
| Smrkovski, OA | 1 |
| Lee, J | 3 |
| Smith, AN | 1 |
| Phillips, JC | 1 |
| Nanno, S | 1 |
| Nakamae, H | 2 |
| Kuwamura, Y | 1 |
| Ishimura, E | 1 |
| Sakabe, M | 1 |
| Inaba, A | 1 |
| Koh, S | 1 |
| Yoshimura, T | 1 |
| Nishimoto, M | 1 |
| Hayashi, Y | 1 |
| Terada, Y | 1 |
| Nakane, T | 2 |
| Koh, H | 2 |
| Nakao, Y | 2 |
| Ohsawa, M | 1 |
| Hino, M | 2 |
| Huang, S | 1 |
| Zheng, ZX | 1 |
| Xu, Q | 1 |
| Yuan, XH | 1 |
| Lee, JA | 1 |
| Jeong, WK | 1 |
| Min, JH | 1 |
| Kim, J | 1 |
| Kraus, TS | 1 |
| Twist, CJ | 1 |
| Tan, BT | 1 |
| Zhao, Q | 1 |
| Liu, HP | 1 |
| Gu, YJ | 1 |
| Cong, WM | 1 |
| Liu, QF | 1 |
| Wang, WH | 1 |
| Wang, SL | 1 |
| Liu, YP | 1 |
| Huang, WT | 1 |
| Lu, N | 1 |
| Zhou, LQ | 2 |
| Ouyang, H | 1 |
| Jin, J | 2 |
| Li, YX | 1 |
| Pellegrini, C | 1 |
| Celli, M | 1 |
| Argnani, L | 1 |
| Agostinelli, C | 1 |
| Pileri, S | 2 |
| Ramanathan, A | 1 |
| Mahmoud, HA | 1 |
| Hui, LP | 1 |
| Mei, NY | 1 |
| Valliappan, V | 1 |
| Zain, RB | 1 |
| Kazi, M | 1 |
| Ikram, M | 1 |
| Junaid, M | 1 |
| Marchetti, M | 1 |
| Barosi, G | 1 |
| Billio, A | 1 |
| Gallamini, A | 1 |
| Pimpinelli, N | 1 |
| Rossi, G | 1 |
| Tura, S | 1 |
| Yap, E | 1 |
| Wan Jamaluddin, WF | 1 |
| Tumian, NR | 1 |
| Mashuri, F | 1 |
| Mohammed, F | 1 |
| Tan, GC | 1 |
| Masir, N | 1 |
| Abdul Wahid, FS | 1 |
| Lin, N | 1 |
| Song, Y | 1 |
| Zheng, W | 2 |
| Tu, M | 1 |
| Xie, Y | 2 |
| Wang, X | 1 |
| Ying, Z | 1 |
| Ping, L | 1 |
| Zhang, C | 1 |
| Liu, W | 1 |
| Zhu, J | 3 |
| Yoshimori, M | 1 |
| Takada, H | 1 |
| Imadome, K | 1 |
| Kurata, M | 1 |
| Yamamoto, K | 1 |
| Koyama, T | 1 |
| Shimizu, N | 1 |
| Fujiwara, S | 1 |
| Miura, O | 1 |
| Arai, A | 1 |
| Kakinoki, Y | 1 |
| Hashiguchi, J | 1 |
| Ishio, T | 1 |
| Chiba, K | 1 |
| Niino, D | 1 |
| Ohshima, K | 4 |
| Siraj, F | 1 |
| Dalal, V | 1 |
| Khan, AA | 1 |
| Jain, D | 1 |
| Kryachok, IA | 1 |
| Aleksyk, OM | 1 |
| Zou, H | 1 |
| Pan, KH | 1 |
| Wu, L | 1 |
| Pan, HY | 1 |
| Ding, YH | 1 |
| Zheng, MH | 1 |
| Ishii, Y | 1 |
| Itabashi, M | 1 |
| Numata, A | 1 |
| Yamamoto, W | 1 |
| Motohashi, K | 1 |
| Hagihara, M | 1 |
| Matsumoto, K | 1 |
| Fujisawa, S | 2 |
| Ma, H | 1 |
| Abdul-Hay, M | 1 |
| Wan, WL | 1 |
| Wang, J | 2 |
| Zhu, MX | 1 |
| Zhang, W | 1 |
| Ke, XY | 1 |
| Tan, DS | 1 |
| Eng, PC | 1 |
| Lim, ST | 1 |
| Thye, LS | 1 |
| Tao, M | 1 |
| Kang, HJ | 2 |
| Ryoo, BY | 2 |
| Huh, J | 1 |
| Ko, YH | 5 |
| Eom, HS | 1 |
| Kim, K | 4 |
| Park, K | 5 |
| Kim, WS | 5 |
| Chang, PM | 1 |
| Chen, PM | 1 |
| Hsieh, SL | 1 |
| Tzeng, CH | 1 |
| Liu, JH | 1 |
| Chiou, TJ | 1 |
| Wang, WS | 1 |
| Yen, CC | 1 |
| Gau, JP | 1 |
| Yang, MH | 1 |
| Li, XQ | 3 |
| Ma, X | 2 |
| Hong, X | 2 |
| Lu, H | 2 |
| Guo, Y | 4 |
| Guo, HY | 1 |
| Zhao, XM | 1 |
| Cao, JN | 1 |
| Hu, XC | 1 |
| Yin, JL | 2 |
| Hong, XN | 2 |
| Kircher, SM | 2 |
| Gurbuxani, S | 2 |
| Smith, SM | 2 |
| O'Connor, OA | 1 |
| Shustov, AR | 1 |
| Savage, KJ | 1 |
| Okazaki, T | 1 |
| Maeda, A | 1 |
| Inoue, M | 1 |
| Kitazono, T | 1 |
| Shibata, T | 1 |
| Ozaki, S | 1 |
| Nickelsen, M | 3 |
| Ziepert, M | 2 |
| Zeynalova, S | 1 |
| Glass, B | 3 |
| Metzner, B | 3 |
| Leithaeuser, M | 1 |
| Mueller-Hermelink, HK | 1 |
| Pfreundschuh, M | 6 |
| Schmitz, N | 6 |
| Tong, H | 1 |
| Ren, Y | 1 |
| Qian, W | 1 |
| Xiao, F | 1 |
| Mai, W | 1 |
| Meng, H | 1 |
| Togashi, M | 1 |
| Wakui, H | 1 |
| Kodama, K | 1 |
| Kameoka, Y | 1 |
| Komatsuda, A | 1 |
| Nimura, T | 1 |
| Ichinohasama, R | 2 |
| Sawada, K | 1 |
| Derungs, A | 1 |
| Rätz Bravo, AE | 1 |
| Kummer, O | 1 |
| Trümper, L | 4 |
| Ho, AD | 1 |
| Peter, N | 1 |
| Loeffler, M | 5 |
| Rosenwald, A | 1 |
| Lü, Z | 1 |
| Shi, YK | 1 |
| Qin, Y | 1 |
| Dong, M | 1 |
| Yang, JL | 1 |
| Liu, P | 1 |
| Zhang, CG | 1 |
| Blom, E | 1 |
| Heyning, FH | 1 |
| Kroes, WG | 1 |
| Mixon, B | 1 |
| Drach, L | 1 |
| Monforte, H | 1 |
| Barbosa, J | 1 |
| Shimizu, I | 1 |
| Nasu, K | 1 |
| Sato, K | 1 |
| Ueki, H | 1 |
| Akahane, D | 1 |
| Sumi, M | 1 |
| Ueno, M | 1 |
| Ichikawa, N | 1 |
| Asano, N | 1 |
| Kojima, M | 1 |
| Nakayama-Ichiyama, S | 1 |
| Yokote, T | 1 |
| Kobayashi, K | 1 |
| Hirata, Y | 1 |
| Hiraoka, N | 1 |
| Iwaki, K | 1 |
| Takayama, A | 1 |
| Akioka, T | 1 |
| Oka, S | 1 |
| Miyoshi, T | 1 |
| Fukui, H | 1 |
| Tsuda, Y | 1 |
| Takubo, T | 1 |
| Tsuji, M | 1 |
| Higuchi, K | 1 |
| Hanafusa, T | 1 |
| Rebhun, RB | 1 |
| Kent, MS | 1 |
| Borrofka, SA | 1 |
| Frazier, S | 1 |
| Skorupski, K | 1 |
| Rodriguez, CO | 1 |
| Zhan, HQ | 1 |
| Zhu, XZ | 1 |
| Zhou, XY | 1 |
| Babb, A | 1 |
| Zerizer, I | 1 |
| Naresh, KN | 1 |
| Macdonald, D | 1 |
| Zhao, S | 1 |
| Zhang, M | 1 |
| Yao, G | 1 |
| Zhang, X | 1 |
| Zhao, W | 1 |
| Ren, W | 1 |
| Zhang, Q | 1 |
| Tsukasaki, K | 1 |
| Tobinai, K | 4 |
| Hotta, T | 1 |
| Shimoyama, M | 2 |
| Yang, QX | 1 |
| Pei, XJ | 1 |
| Tian, XY | 1 |
| Li, Y | 1 |
| Li, Z | 1 |
| Delfau-Larue, MH | 1 |
| de Leval, L | 1 |
| Joly, B | 1 |
| Plonquet, A | 1 |
| Challine, D | 1 |
| Parrens, M | 1 |
| Delmer, A | 2 |
| Salles, G | 1 |
| Morschhauser, F | 1 |
| Delarue, R | 1 |
| Brice, P | 1 |
| Bouabdallah, R | 2 |
| Casasnovas, O | 1 |
| Tilly, H | 1 |
| Gaulard, P | 3 |
| Haioun, C | 2 |
| Canpolat, U | 1 |
| Sunman, H | 1 |
| Kaya, EB | 1 |
| Aytemir, K | 1 |
| Glaß, B | 1 |
| Xu, L | 1 |
| Gupta, A | 1 |
| Garber, J | 1 |
| Fowlkes, N | 1 |
| Rademacher, N | 1 |
| Shiomitsu, K | 1 |
| Evans, DE | 1 |
| Gaunt, SD | 1 |
| Acree, SC | 1 |
| Tovar, JP | 1 |
| Pattengale, PK | 1 |
| Wang, LL | 1 |
| Church, JA | 1 |
| Gaynon, PS | 1 |
| Cassarino, DS | 1 |
| Beckers, MM | 1 |
| Huls, G | 1 |
| Lai, WS | 1 |
| Wang, CH | 1 |
| Shih, CP | 1 |
| Chang, CC | 1 |
| Bunyi-Teopengco, E | 1 |
| Eshoa, C | 1 |
| Chitambar, CR | 1 |
| Kampalath, B | 1 |
| Sawada, M | 1 |
| Yamada, T | 1 |
| Tsurumi, H | 1 |
| Moriwaki, H | 1 |
| Mottl, H | 1 |
| Bajciova, V | 1 |
| Nemec, J | 1 |
| Al Shemmari, S | 1 |
| Al Awadi, S | 1 |
| Kataoka, I | 1 |
| Arima, F | 1 |
| Nishimoto, J | 1 |
| Watanabe, T | 1 |
| Kobayashi, Y | 1 |
| Tamura, R | 1 |
| Yamamoto, S | 1 |
| Matsuno, Y | 1 |
| Shimoda, T | 1 |
| Zamkoff, KW | 1 |
| Bergman, S | 1 |
| Beaty, MW | 1 |
| Buss, DH | 1 |
| Pettenati, MJ | 1 |
| Hurd, DD | 1 |
| Kim, YB | 1 |
| Chang, SK | 1 |
| Yang, WI | 1 |
| Hahn, JS | 1 |
| Koom, WS | 1 |
| Shim, SJ | 1 |
| Park, W | 1 |
| Lee, KK | 1 |
| Suh, CO | 1 |
| Kim, GE | 1 |
| Tsujisaki, M | 1 |
| Nakahara, S | 1 |
| Kazama, Y | 1 |
| Shimizu, H | 1 |
| Yoshimoto, M | 1 |
| Takahashi, T | 1 |
| Okada, Y | 1 |
| Sasaki, S | 2 |
| Imai, K | 1 |
| Okada, M | 1 |
| Maeda, K | 3 |
| Suzumiya, J | 1 |
| Hagimoto, T | 1 |
| Wakamatsu, S | 1 |
| Kanda, M | 1 |
| Sonoda, T | 1 |
| Sakamoto, A | 1 |
| Tamura, K | 1 |
| Mahmal, L | 1 |
| Jabri, A | 1 |
| Jabri, L | 1 |
| Harif, M | 1 |
| Quessari, A | 1 |
| Benchakroun, Y | 1 |
| Iraqi, A | 1 |
| Benchekroun, S | 1 |
| Wunderlich, A | 1 |
| Kloess, M | 4 |
| Reiser, M | 3 |
| Rudolph, C | 3 |
| Truemper, L | 1 |
| Bittner, S | 1 |
| Schmalenberg, H | 1 |
| Schmits, R | 3 |
| Varadarajulu, S | 1 |
| Lewin, D | 1 |
| Horiuhi, T | 1 |
| Nomura, J | 1 |
| Okuda, M | 1 |
| Beyeler, M | 1 |
| Dummer, R | 1 |
| Giunta, R | 1 |
| Cravero, RG | 1 |
| Granata, G | 1 |
| Sellitto, A | 1 |
| Romano, C | 1 |
| De Fanis, U | 1 |
| Foccillo, G | 1 |
| De Capite, C | 1 |
| Santini, M | 1 |
| Rossiello, L | 1 |
| Rossiello, R | 1 |
| Lucivero, G | 1 |
| Shiratsuchi, M | 1 |
| Suehiro, Y | 1 |
| Yoshikawa, Y | 1 |
| Shiokawa, S | 1 |
| Nishimura, J | 2 |
| Feller, AC | 2 |
| Hossfeld, DK | 2 |
| Hasenclever, D | 2 |
| Rübe, C | 2 |
| Eimermacher, H | 1 |
| De Samblanx, H | 1 |
| Verhoef, G | 1 |
| Zachée, P | 1 |
| Vandenberghe, P | 1 |
| Kouzaki, H | 1 |
| Kitanishi, T | 1 |
| Kitano, H | 1 |
| Suzuki, M | 1 |
| Inagaki, N | 1 |
| Asaoka, D | 1 |
| Mori, KL | 1 |
| Sohda, N | 1 |
| Miura, I | 1 |
| Miwa, H | 1 |
| Sato, N | 1 |
| Oshimi, K | 1 |
| Adams, AE | 1 |
| Zwicker, J | 1 |
| Curiel, C | 1 |
| Kadin, ME | 1 |
| Falchuk, KR | 1 |
| Drews, R | 1 |
| Kupper, TS | 1 |
| Nishioka, T | 1 |
| Tsuchiya, K | 1 |
| Nishioka, S | 1 |
| Kitahara, T | 1 |
| Ohmori, K | 1 |
| Homma, A | 1 |
| Aoyma, H | 1 |
| Shindoh, M | 1 |
| Shirato, H | 1 |
| Tong, GX | 1 |
| Hernandez, O | 1 |
| Yee, HT | 1 |
| Zheng, SH | 1 |
| Yang, GC | 1 |
| Gardner, RV | 1 |
| Velez, MC | 1 |
| Ode, DL | 1 |
| Lee, JW | 1 |
| Correa, H | 1 |
| Wöhrer, S | 1 |
| Chott, A | 1 |
| Drach, J | 1 |
| Püspök, A | 1 |
| Hejna, M | 1 |
| Hoffmann, M | 1 |
| Raderer, M | 1 |
| Yong, WB | 1 |
| Zhang, YT | 1 |
| Wang, XP | 1 |
| Cho, KJ | 1 |
| Cho, SG | 1 |
| Lee, DH | 1 |
| Sokolov, AH | 1 |
| Parovichnikova, EN | 1 |
| Isaev, VG | 1 |
| Ustinova, EN | 1 |
| Shavlokhov, VS | 1 |
| Atopkov, VA | 1 |
| Model, SV | 1 |
| Tsyba, NN | 1 |
| Kaplanskaia, IB | 1 |
| Kliasova, GA | 1 |
| Aleksanian, MZh | 1 |
| Vishnevskaia, ES | 1 |
| Togonidze, DK | 1 |
| Mirzoian, EE | 1 |
| Savchenko, VG | 1 |
| Escalón, MP | 1 |
| Liu, NS | 1 |
| Yang, Y | 1 |
| Hess, M | 1 |
| Walker, PL | 1 |
| Smith, TL | 1 |
| Dang, NH | 1 |
| Hou, M | 1 |
| Li, L | 1 |
| Qiu, M | 1 |
| Yan, X | 1 |
| Gou, HF | 1 |
| Coiffier, B | 2 |
| Reyes, F | 1 |
| Park, BB | 1 |
| Park, KW | 1 |
| Kang, JH | 1 |
| Lee, SH | 2 |
| Park, JO | 1 |
| Jung, CW | 2 |
| Park, YS | 1 |
| Im, YH | 1 |
| Kang, WK | 2 |
| Lee, MH | 1 |
| Pan, ZH | 2 |
| Huang, HQ | 5 |
| Lin, XB | 2 |
| Xia, YF | 2 |
| Xia, ZJ | 4 |
| Peng, YL | 1 |
| Cai, QQ | 2 |
| Lin, TY | 4 |
| Jiang, WQ | 3 |
| Guan, ZZ | 6 |
| Bentz, M | 1 |
| Schlimok, G | 1 |
| Berdel, WE | 1 |
| Feller, A | 2 |
| Miyazaki, K | 1 |
| Masuya, M | 1 |
| Yamaguchi, M | 1 |
| Isaka, S | 1 |
| Nakase, K | 1 |
| Kobayashi, T | 1 |
| Nakamura, S | 1 |
| Shiku, H | 1 |
| Yamane, T | 1 |
| Hirose, A | 1 |
| Nakajima, Y | 1 |
| Takeoka, Y | 1 |
| Nakamae, M | 1 |
| Yamamura, R | 1 |
| Mugitani, A | 1 |
| Yagi, T | 1 |
| Teshima, H | 1 |
| Medlicott, SA | 1 |
| Coderre, S | 1 |
| Horne, G | 1 |
| Panaccione, R | 1 |
| Ahn, YC | 2 |
| Park, YH | 1 |
| Bang, SM | 1 |
| Lee, SI | 1 |
| Na, II | 1 |
| Yang, SH | 1 |
| Lee, SS | 1 |
| Uhm, JE | 1 |
| Kwon, JM | 1 |
| Lin, CY | 2 |
| Yeh, SP | 1 |
| Huang, HH | 1 |
| Liao, YM | 1 |
| Chiu, CF | 1 |
| Yi, JQ | 1 |
| He, YJ | 3 |
| Xu, RH | 3 |
| Shipp, M | 1 |
| Wahie, S | 1 |
| Alexandroff, A | 1 |
| Reynolds, NJ | 1 |
| Meggit, SJ | 1 |
| Fischbach, W | 1 |
| Sung, HJ | 2 |
| Seo, HY | 2 |
| Sul, HR | 1 |
| Choi, JG | 1 |
| Choi, IK | 1 |
| Park, KH | 1 |
| Oh, SC | 1 |
| Seo, JH | 1 |
| Choi, CW | 2 |
| Kim, BS | 2 |
| Shin, SW | 1 |
| Kim, YH | 1 |
| Kim, JS | 2 |
| Rongey, C | 1 |
| Micallef, I | 1 |
| Smyrk, T | 1 |
| Murray, J | 2 |
| Sun, XF | 1 |
| Zhen, ZJ | 1 |
| Lui, DG | 1 |
| Xia, Y | 1 |
| Wang, ZH | 1 |
| Lin, JY | 1 |
| Seol, HR | 1 |
| Kim, IS | 1 |
| Kim, CY | 1 |
| Jung, KY | 1 |
| Xiao, J | 1 |
| Wang, SS | 2 |
| Huang, Y | 1 |
| Chen, LK | 1 |
| Ichii, M | 1 |
| Hatanaka, K | 2 |
| Imakita, M | 1 |
| Ueda, Y | 1 |
| Kishino, B | 1 |
| Tamaki, T | 1 |
| Wang, BY | 1 |
| Lu, HF | 1 |
| Ma, XJ | 1 |
| Cao, YB | 1 |
| Xu, GC | 1 |
| Lu, JJ | 1 |
| Win, N | 1 |
| Tiwari, D | 1 |
| Keevil, VL | 1 |
| Needs, M | 1 |
| Lakhani, A | 1 |
| Imafuku, S | 1 |
| Yoshimura, D | 1 |
| Moroi, Y | 1 |
| Urabe, K | 1 |
| Furue, M | 1 |
| Su, ZY | 1 |
| Zhang, DS | 1 |
| Zhu, MQ | 1 |
| Shi, YX | 1 |
| Bu, Q | 1 |
| Gao, Y | 1 |
| Wang, BF | 1 |
| Gleason, BC | 1 |
| Brinster, NK | 1 |
| Granter, SR | 1 |
| Pinkus, GS | 1 |
| Lindeman, NI | 1 |
| Miller, DM | 1 |
| Shikama, N | 1 |
| Koiwai, K | 1 |
| Kadoya, M | 1 |
| Leitenberger, JJ | 1 |
| Berthelot, CN | 1 |
| Polder, KD | 1 |
| Pro, B | 1 |
| McLaughlin, P | 1 |
| Jones, D | 1 |
| Duvic, M | 1 |
| Mourad, N | 1 |
| Mounier, N | 1 |
| Brière, J | 1 |
| Raffoux, E | 1 |
| Meijer, CJ | 1 |
| Emile, JF | 1 |
| Bosly, A | 1 |
| Diebold, J | 2 |
| Gisselbrecht, C | 1 |
| Yang, H | 1 |
| Shen, T | 1 |
| Cimino, L | 1 |
| Chan, CC | 1 |
| Shen, D | 1 |
| Masini, L | 1 |
| Ilariucci, F | 1 |
| Masetti, M | 1 |
| Asioli, S | 1 |
| Sartori, A | 1 |
| Cappuccini, L | 1 |
| Lee, JY | 1 |
| Jang, YD | 1 |
| Kim, HK | 1 |
| Ghosh, K | 1 |
| Sivakumaran, M | 1 |
| Murphy, P | 1 |
| Chapman, CS | 1 |
| Wood, JK | 1 |
| Mahlknecht, A | 1 |
| Gallmetzer, J | 1 |
| Späth, M | 1 |
| Schollmeyer, P | 1 |
| Nagatani, T | 1 |
| Baba, N | 1 |
| Nakajima, H | 1 |
| Rysenga, E | 1 |
| Linden, MD | 1 |
| Carey, JL | 1 |
| Ross, CW | 1 |
| Schnitzer, B | 1 |
| Sawdyk, M | 1 |
| Lees, CC | 1 |
| Tsirigotis, M | 1 |
| Carr, JV | 1 |
| Richards, MA | 1 |
| Boon, ES | 1 |
| Graal, MB | 1 |
| van Noord, JA | 1 |
| Uthman, I | 1 |
| Vázquez-Abad, D | 1 |
| Senécal, JL | 1 |
| Kamiya, I | 1 |
| Sepandj, F | 1 |
| Gupta, R | 1 |
| Foyle, A | 1 |
| Karakas, T | 1 |
| Bergmann, L | 1 |
| Stutte, HJ | 1 |
| Jäger, E | 1 |
| Knuth, A | 1 |
| Weidmann, E | 1 |
| Mitrou, PS | 1 |
| Hoelzer, D | 1 |
| Drénou, B | 1 |
| Lamy, T | 1 |
| Amiot, L | 1 |
| Fardel, O | 1 |
| Caulet-Maugendre, S | 1 |
| Sasportes, M | 1 |
| Le Prisé, PY | 1 |
| Fauchet, R | 1 |
| Pimentel, M | 1 |
| Johnston, JB | 1 |
| Allan, DR | 1 |
| Greenberg, H | 1 |
| Bernstein, CN | 1 |
| Brada, M | 1 |
| Hjiyiannakis, D | 1 |
| Hines, F | 1 |
| Traish, D | 1 |
| Ashley, S | 1 |
| Sonobe, M | 1 |
| Yasuda, H | 1 |
| Okabe, H | 1 |
| Terada, M | 1 |
| Kawabata, T | 1 |
| Kikkawa, R | 1 |
| Pieters, R | 1 |
| den Boer, ML | 1 |
| Durian, M | 1 |
| Janka, G | 1 |
| Schmiegelow, K | 1 |
| Kaspers, GJ | 1 |
| van Wering, ER | 1 |
| Veerman, AJ | 1 |
| Orlandi, E | 1 |
| Lazzarino, M | 1 |
| Bernasconi, P | 1 |
| Astori, C | 1 |
| Bernasconi, C | 1 |
| Karakuş, S | 1 |
| Yalçin, S | 1 |
| Güler, N | 1 |
| Cöplü, L | 1 |
| Ayhan, A | 1 |
| Motomura, S | 2 |
| Fujimaki, K | 1 |
| Tanabe, J | 1 |
| Tomita, N | 1 |
| Hara, M | 1 |
| Mohri, H | 1 |
| Derbel, M | 1 |
| Ben Zina, Z | 1 |
| Sellami, D | 1 |
| Ben Ayed, H | 1 |
| Chaabouni, M | 1 |
| Daoud, J | 1 |
| Frikha, M | 1 |
| Abdelmoula, M | 1 |
| Minami, R | 1 |
| Hirase, N | 1 |
| Muta, K | 1 |
| Nawata, H | 1 |
| Loudon, JA | 1 |
| Marsh, WL | 1 |
| Allen, CM | 1 |
| Jillella, AP | 1 |
| Day, DS | 1 |
| Severson, K | 1 |
| Kallab, AM | 1 |
| Burgess, R | 1 |
| Suarez, F | 1 |
| Wlodarska, I | 1 |
| Rigal-Huguet, F | 1 |
| Mempel, M | 1 |
| Martin-Garcia, N | 1 |
| Farcet, JP | 1 |
| Delsol, G | 1 |
| Tsujimura, H | 1 |
| Takagi, T | 1 |
| Tamaru, J | 1 |
| Sakai, C | 1 |
| Tauro, S | 1 |
| Dobie, D | 1 |
| Richardson, G | 1 |
| Hastings, M | 1 |
| Mahendra, P | 1 |
| Niitsu, N | 1 |
| Iijima, K | 1 |
| Chizuka, A | 1 |
| Yamazaki, M | 1 |
| Kakuta, M | 1 |
| Takimoto, R | 1 |
| Murayama, N | 1 |
| Takamori, K | 1 |
| Miyagishima, T | 1 |
| Kamata, T | 1 |
| Nakagawa, M | 1 |
| Miura, Y | 1 |
| Arai, S | 1 |
| Kishimoto, A | 1 |
| Kamishima, Y | 1 |
| Shibata, M | 1 |
| Choi, GH | 1 |
| Kudo, M | 1 |
| Okabe, M | 1 |
| Tsukamoto, T | 1 |
| Miyamoto, K | 1 |
| Pulte, D | 1 |
| Nakamura, K | 1 |
| Asahina, A | 1 |
| Tamaki, K | 1 |
| Kirk, CM | 1 |
| Naumann, RW | 1 |
| Hartmann, CJ | 1 |
| Brown, CA | 1 |
| Banks, PM | 1 |
| Song, SY | 1 |
| Baek, CH | 1 |
| Kim, DY | 1 |
| Yoon, SS | 1 |
| Lee, HG | 1 |
| Lee, HJ | 1 |
| Park, CH | 1 |
| Mandel, L | 1 |
| Surattanont, F | 1 |
| Dourmas, M | 1 |
| Krieger, G | 1 |
| Kreysing, E | 1 |
| Kneba, M | 1 |
| Grenzebach, J | 1 |
| Schrappe, M | 1 |
| Ludwig, WD | 1 |
| Parwaresch, R | 1 |
| Zimmermann, M | 1 |
| Gadner, H | 1 |
| Riehm, H | 1 |
| Reiter, A | 1 |
| Giménez-Mesa, E | 1 |
| Martínez-Salio, A | 1 |
| Porta-Etessam, J | 1 |
| Berbel García, A | 1 |
| Cedena Romero, T | 1 |
| Salama Bendoyan, P | 1 |
| Al Omran, S | 1 |
| Mourad, WA | 1 |
| Ali, MA | 1 |
| Motta, G | 1 |
| Vianello, F | 1 |
| Menin, C | 1 |
| De Nicolo, A | 1 |
| Agata, S | 1 |
| Altavilla, G | 1 |
| Pietrogrande, F | 1 |
| Girolami, A | 1 |
| Cornfield, DB | 1 |
| Papiez, JS | 1 |
| Lynch, JT | 1 |
| Rimsza, LM | 1 |
| Dommann-Scherrer, C | 1 |
| Zimmermann, D | 1 |
| Hassam, S | 1 |
| Odermatt, BF | 1 |
| Risti, B | 1 |
| Maurer, R | 1 |
| Shiong, YS | 1 |
| Lian, JD | 1 |
| Shu, KH | 1 |
| Lu, YS | 1 |
| Chou, G | 1 |
| Siegert, W | 1 |
| Agthe, A | 1 |
| Griesser, H | 1 |
| Schwerdtfeger, R | 1 |
| Brittinger, G | 1 |
| Engelhard, M | 1 |
| Kuse, R | 1 |
| Tiemann, M | 1 |
| Lennert, K | 1 |
| Huhn, D | 1 |
| Kwak, LW | 1 |
| Wilson, M | 1 |
| Weiss, LM | 1 |
| Doggett, R | 1 |
| Dorfman, RF | 1 |
| Warnke, RA | 1 |
| Horning, SJ | 1 |
| Liang, R | 1 |
| Chiu, E | 1 |
| Chan, TK | 1 |
| Todd, D | 1 |
| Loke, SL | 1 |
| Asano, Y | 1 |
| Yoshizawa, S | 1 |
| Shiraishi, G | 1 |
| Kato, K | 1 |
| Olesen, LL | 1 |
| Mølby, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| CHOP-Campath, A Pilot Study of CHOP Plus Campath for the Primary Treatment of ALK-ve Peripheral T Cell Lymphoma [CHOP-CAMPATH][NCT00562068] | Phase 1 | 30 participants (Anticipated) | Interventional | 2007-05-31 | Recruiting | ||
| Nivolumab With Standard of Care Chemotherapy for the First Line Treatment of Peripheral T Cell Lymphoma[NCT03586999] | Phase 1/Phase 2 | 18 participants (Actual) | Interventional | 2018-11-07 | Active, not recruiting | ||
| Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.[NCT03964480] | 1,000 participants (Anticipated) | Observational [Patient Registry] | 2018-10-14 | Recruiting | |||
| LINFOTARGAM: First-line Treatment With Dose-dense Chemotherapy Plus Rituximab (R-CHOP/14) and Highly Active Antiretroviral Therapy (HAART) in Patients With Diffuse Large B Cell Lymphoma (DLBCL) and Infection With the Human Immunodeficiency Virus (HIV)[NCT00466258] | Phase 4 | 50 participants (Anticipated) | Interventional | 2006-10-31 | Completed | ||
| Prospective Observational Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell[NCT02916316] | 127 participants (Actual) | Observational | 2014-02-12 | Active, not recruiting | |||
| Intensified CHOP Plus Rituximab (R-CHOP 14) Versus CHOP Plus Rituximab (R-CHOP 21) and Frontline/Prophylactic Darbepoetin Alfa Treatment Versus Usual Symptomatic Treatment of Anemia in Patients Aged 60 to 80 Years With Diffuse Large B-cell Lymphoma.[NCT00144755] | Phase 3 | 600 participants (Actual) | Interventional | 2003-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
30 reviews available for prednisone and T-Cell Lymphoma
| Article | Year |
|---|---|
Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus In | 2023 |
Angioimmunoblastic T-Cell Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Cyclophosphamide; Disease-Free Survival; | 2017 |
Orbital T-cell lymphoma in youngest recorded patient - early diagnosis, management, and successful outcome: a case report and review of the literature.
Topics: Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Da | 2018 |
Cryoglobulinemic Glomerulonephritis Associated With Nodal and Renal Infiltration by T-Cell Lymphoma of T-Follicular Helper Phenotype: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Marrow; Cryoglobulinemia | 2018 |
Angioimmunoblastic T-cell lymphoma with intramedullary production of platelet-derived growth factor and possibly complicating myelofibrosis: report of a case with review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Cytokines; Doxo | 2013 |
[Angioimmunoblastic T cell lymphoma complicated with endocapillary proliferative glomerulonephritis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Female | 2013 |
CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy | 2015 |
Nasal NK/T cell lymphoma presents with long-term nasal blockage and fever: a rare case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lympho | 2016 |
T-cell lymphomas, a challenging disease: types, treatments, and future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ki | 2017 |
Lymphadenopathy of IgG4-related sclerosing disease: three case reports and review of literature.
Topics: Aged; Female; Glucocorticoids; Humans; Immunoglobulin G; Lymphatic Diseases; Lymphoid Tissue; Lympho | 2010 |
Lymphoma study group of JCOG.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemother | 2012 |
Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomar | 2012 |
Autologous or allogeneic transplantation in B- and T-cell lymphomas.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 2012 |
Primary NK/T cell lymphoma of the testis. A case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Doxorubici | 2003 |
[Standard and experimental therapy of cutaneous T-cell lymphoma].
Topics: Adrenal Cortex Hormones; Aminoquinolines; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Anti | 2003 |
Primary cardiac T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Cyclophosphami | 2004 |
A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis.
Topics: Adrenal Cortex Hormones; Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Biops | 2004 |
Natural killer T-cell lymphoma of the tongue.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxo | 2005 |
Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Do | 2005 |
Perianal tuberculosis during neutropenia: a rare case report and review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Anus Diseases; Cyclophosphami | 2006 |
[Primary central nervous system lymphoma--a report of 32 cases with literature review].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Chi | 2006 |
[Gastric lyphoma - still a result of surgery?].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2006 |
[Primary breast lymphoma--a report of 27 cases with literature review].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast N | 2007 |
Intravascular cytotoxic T-cell lymphoma: A case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Erythema; Humans; Lym | 2008 |
T cell non-Hodgkin's lymphoma presenting in the first trimester of pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans | 1994 |
[Recent progress in the treatment of malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 1994 |
[Chemotherapy for malignant lymphoma in Western countries and Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, | 1993 |
[A case of T-cell malignant lymphoma developing in the chest wall of chronic pyothorax after artificial pneumothorax].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclophosphamide; Doxorubicin | 1996 |
Primary adrenal lymphoma associated with adrenal insufficiency: a distinct clinical entity.
Topics: Addison Disease; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adult; Antineoplastic Combined Ch | 1997 |
[Reversible posterior leukoencephalopathy in a patient with non-Hodgkin's lymphoma after treatment with CHOP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Cyclophosphamide; Doxorubicin; Femal | 2001 |
18 trials available for prednisone and T-Cell Lymphoma
156 other studies available for prednisone and T-Cell Lymphoma
| Article | Year |
|---|---|
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.
Topics: Administration, Metronomic; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; | 2018 |
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2022 |
Spatial Transcriptomics Analysis Reveals that CCL17 and CCL22 are Robust Indicators of a Suppressive Immune Environment in Angioimmunoblastic T Cell Lymphoma (AITL).
Topics: Chemokine CCL17; Chemokine CCL22; Cyclophosphamide; Doxorubicin; Humans; Immunoblastic Lymphadenopat | 2022 |
Calculation of dose intensity and comparison of published methods using a cohort of canine T-cell lymphoma patients undergoing CHOP-based chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Doxor | 2023 |
Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Survival; Cyclo | 2019 |
Epstein-Barr Virus-Induced Cutaneous Diffuse Large B-Cell Lymphoma in a Patient With Angioimmunoblastic T-Cell Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus In | 2019 |
Composite lymphoma of concurrent T zone lymphoma and large cell B cell lymphoma in a dog.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Chlorambucil; Dog Disea | 2019 |
MicroRNA profiling in canine multicentric lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Dog Di | 2019 |
Pralatrexate-based therapy induced response in an adolescent with refractory hepatosplenic T-cell lymphoma.
Topics: Adolescent; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 2020 |
Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Examination; Cyclop | 2020 |
Chemotherapy combined with radiotherapy for successful treatment of angioimmunoblastic T-cell lymphoma: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Immunob | 2020 |
LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lomustine; Lymp | 2018 |
Gamma-delta (γδ) T-cell lymphoma - another case unclassifiable by World Health Organization classification: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Cyclophosphamide; Dox | 2017 |
Primary Pulmonary Extranodal Natural Killer/T-cell Lymphoma, Nasal Type Presenting as Diffuse Ground Glass Opacities: a Case Report.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis | 2017 |
Orbital T-cell lymphoma versus lupus panniculitits: a T-cell-mediated spectrum of orbital lymphoproliferative disease.
Topics: Administration, Oral; Adult; Diagnosis, Differential; Glucocorticoids; Humans; Immunosuppressive Age | 2018 |
A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Cyclophosphamide; Doxorubi | 2018 |
Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; He | 2018 |
Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Cyclophosphamide; Etoposide; F | 2018 |
The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Copy Number Varia | 2019 |
How dogs are teaching researchers new tricks for treating cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Clinical Trials, Veterinar | 2018 |
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxoru | 2019 |
CASE OF DEVELOPMENT OF NON-HODGKIN'S MALIGNANT LYMPHOMA ON THE BACKGROUND OF CHRONIC MYELOID LEUKEMIA IN A PATIENT WHO SUFFERED OF THE CHORNOBYL ACCIDENT.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chernobyl Nuclear Accident; C | 2018 |
Subcutaneous panniculitis-like T-cell lymphoma responsive to combination therapy with methotrexate and corticosteroids.
Topics: Anti-Inflammatory Agents; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Immunosuppre | 2018 |
Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; | 2019 |
Beneficial effect of consolidative radiotherapy for patients with lymphoma and skeletal involvement.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Case-Control Studies; Combine | 2019 |
A case of CD20-positive peripheral T-cell lymphoma treated with rituximab and multiagent chemotherapy.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; An | 2014 |
Primary T-cell lymphoma of liver.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Diagnosis, Dif | 2013 |
Histologic transformation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; | 2013 |
Malignant epithelioid angiomyolipoma: tumor and metabolic response to everolimus as evaluated with positron emission tomography.
Topics: Angiomyolipoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophospham | 2013 |
Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lymphoma; Lymph | 2015 |
[Diagnosis and treatment of primary colorectal non-Hodgkin's lymphoma: analysis of 52 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Col | 2013 |
Primary hepatic lymphoma mimicking acute hepatitis.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female | 2013 |
Angioimmunoblastic T cell lymphoma: an unusual presentation of posttransplant lymphoproliferative disorder in a pediatric patient.
Topics: Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; | 2014 |
[Clinicopathological and survival features of primary hepatic lymphoma: an analysis of 35 cases].
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antigens, CD20; Antineoplastic Combined Chemotherapy Pr | 2013 |
Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy | 2014 |
Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cycl | 2014 |
Oral extranodal non Hodgkin's lymphoma: series of forty two cases in Malaysia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Burkitt | 2014 |
Nasal T cell lymphoma: a rare entity.
Topics: Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biopsy; CD56 Antigen; Che | 2014 |
SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 2014 |
NK/T cell lymphoma associated with peripheral eosinophilia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Eosinophilia; E | 2014 |
[Non-upper aerodigestive tract NK/T- cell lymphoma: an analysis of clinical features and survival from a single center in China].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi | 2015 |
P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B | 2015 |
Hepatosplenic T-cell lymphoma with coexistent hepatitis B infection: a rare clinicopathologic entity.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Biopsy; Cyclophosphamide; D | 2016 |
[IMMUNOHISTOCHEMICAL FACTORS OF SMALL-CELL LYMPHOMAS AND CHOICE OF TREATMENT WTTH LEVEL INCLUSION].
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Trans | 2014 |
Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Proto | 2016 |
[Retrospective analyses of CHOPE plus L-asparaginase regimen in treatment of T-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Comparative Effectiveness Research; Cy | 2016 |
Primary tracheal lymphoma causing respiratory failure.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 2008 |
Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C | 2008 |
Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Membe | 2008 |
[Prognosis of primary non-Hodgkin's lymphoma of the breast].
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bre | 2008 |
CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review.
Topics: Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; | 2007 |
CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: a case report and literature review.
Topics: Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; | 2007 |
At long last, it's finally 'T' time.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubici | 2008 |
Does high-dose therapy and autologous hematopoietic stem cell transplantation have a role in the primary treatment of peripheral T-cell lymphomas? ASH evidence-based review 2008.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubi | 2008 |
[A case of chronic graft-versus-host disease presenting with polymyositis].
Topics: Bone Marrow Transplantation; Female; Glucocorticoids; Graft vs Host Disease; Humans; Lymphoma, T-Cel | 2009 |
Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi | 2009 |
Angioimmunoblastic T-cell lymphoma and membranous nephropathy: a still unreported association.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Glomerulonephritis, M | 2010 |
[Rash, fever, eosinophilia and elevated liver enzymes. DRESS syndrome (drug reaction or rash with eosinophilia and systemic symptoms)].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
[Primary subcutaneous panniculitis-like T-cell cutaneous lymphoma: clinical presentation, treatment and prognosis].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Child; Combined Mod | 2010 |
A case of angioimmunoblastic T-cell non-Hodgkin lymphoma with a neocentric inv dup(1).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Inversion; Chromosomes, Human, Pair | 2010 |
Subcutaneous panniculitis-like T-cell lymphoma in a child with trisomy 21.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclophosphamide; Down Syndrome; D | 2010 |
Primary effusion lymphoma of T-cell origin with t(7;8)(q32;q13) in an HIV-negative patient with HCV-related liver cirrhosis and hepatocellular carcinoma positive for HHV6 and HHV8.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chromosomes, Human, | 2011 |
CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; California; Cyclopho | 2011 |
[Follicular variant of peripheral T-cell lymphoma: a clinicopathologic and genetic study of 2 cases].
Topics: Aged; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis | 2011 |
Subcutaneous panniculitis-like T-cell lymphoma with extracutaneous dissemination demonstrated on FDG PET/CT.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fluorine Radioisotope | 2011 |
Angioimmunoblastic T-cell lymphoma: the effect of initial treatment and microvascular density in 31 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival | 2012 |
Huge mediastinal mass surrounding the heart.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Heart Neoplas | 2012 |
Ankylosing spondylitis combined with angioimmunoblastic T cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etanercept; Female; H | 2011 |
What is your diagnosis? Abdominal fluid from a dog.
Topics: Animals; Body Fluids; Dog Diseases; Dogs; Fatal Outcome; Female; Gastrointestinal Neoplasms; Lymphom | 2013 |
Subcutaneous Panniculitis-like T-cell lymphoma in two pediatric patients: an HIV-positive adolescent and a 4-month-old infant.
Topics: Adolescent; Anti-Retroviral Agents; HIV Seropositivity; Humans; Immunocompromised Host; Immunosuppre | 2013 |
Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomide.
Topics: Antineoplastic Agents, Hormonal; Humans; Immunoblastic Lymphadenopathy; Lenalidomide; Lymphoma, T-Ce | 2013 |
T-cell lymphoma manifesting as a uvular mass.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Biopsy; Cyclophosphamide; Dox | 2013 |
CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD5 Antigens; Clone Cells; Cyclophosphamide; Disease | 2002 |
[Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Histiocytosis, | 2002 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Presch | 2003 |
Enteropathy-type T-cell lymphoma showing repeated small bowel rupture and refractoriness to chemotherapy: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Huma | 2002 |
Fatal EBV-related post-transplant lymphoproliferative disorder (LPD) after matched related donor nonmyeloablative peripheral blood progenitor cell transplant.
Topics: Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxor | 2003 |
[Immunoblastic lymphadenopathy-like T cell lymphoma with high level of serum interleukin-2 and various allergic reactions].
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Der | 2002 |
Primary colorectal T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Barium Sulfate; Bleomycin; Colonoscopy; Colorectal N | 2003 |
[Primary non-Hodgkin lymphoma of the mandible: apropos of three cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Humans; | 2003 |
Enteropathy-associated T-cell lymphoma involving the colon and extraintestinal B-cell lymphoma in celiac disease.
Topics: Aged; Antineoplastic Agents, Hormonal; Celiac Disease; Colectomy; Colon; Fatal Outcome; Gastrointest | 2003 |
[Abscopal effect of small intestinal NK/T-cell lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fema | 2003 |
Extranodal multiple involvement of enteropathy-type T-cell lymphoma without expression of CC chemokine receptor 7.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Movement; Cisplatin; Cyclophosphamide; Cy | 2004 |
Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cycloph | 2004 |
Enteropathy-type T-cell lymphoma expressing NK-cell intraepithelial lymphocyte (NK-IEL) phenotype.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; CD56 Antigen; Cyclophosphamide; Doxorub | 2004 |
Aggressive cutaneous T-cell lymphomas after TNFalpha blockade.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Crohn Disease; Cyclophospha | 2004 |
Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2004 |
Human T-lymphotropic virus type-1 related adult T-cell leukemia/lymphoma presenting as a parotid mass diagnosed by fine-needle aspiration biopsy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Cyclophosphamide; Diagnosis, Di | 2004 |
Gamma/delta T-cell lymphoma as a recurrent complication after transplantation.
Topics: Adolescent; Cyclosporine; Disease-Free Survival; Female; Humans; Immunoglobulins; Immunohistochemist | 2004 |
[Clinical analysis of liver non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Aspar | 2004 |
[A case of effective use of alemtuzumab in a male patient with T-cell lymphoma].
Topics: Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; | 2004 |
Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alky | 2005 |
IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2005 |
[Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; | 2005 |
[Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; | 2005 |
[High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 2006 |
Multimodal immunosuppressant therapy in steroid-refractory common variable immunodeficiency sprue: a case report complicating cytomegalovirus infection.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antiviral Agents; Azathioprine; Celiac Disease; Com | 2006 |
The effect of pre-irradiation dose intense CHOP on anthracyline resistance in localized nasal NK/T-cell lymphoma.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxor | 2006 |
Primary gastric lymphoma of T-cell origin: clinicopathologic features and treatment outcome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival | 2006 |
New concepts in treatment approaches and prognostic factors in aggressive NHL.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2006 |
Psoriasis occurring after myeloablative therapy and autologous stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lympho | 2006 |
Prospective analysis of treatment outcome and prognostic factors in patients with T-cell lymphomas treated by CEOP-B: single institutional study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Cell | 2006 |
Successful treatment of enteropathy-associated T cell lymphoma with autologous stem cell transplant.
Topics: Abdominal Pain; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophos | 2006 |
Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclo | 2006 |
[Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined | 2006 |
Successful treatment of refractory subcutaneous panniculitis-like T-cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA-mismatched sibling donor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; E | 2006 |
[Prognostic predictors of nasal NK/T cell lymphoma detected by immunohistochemical staining].
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bioma | 2006 |
Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 2007 |
Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodie | 2007 |
Systemic varicella zoster virus reinfection in a case of angioimmunoblastic T-cell lymphoma.
Topics: Acyclovir; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Chickenpox; Cyclo | 2007 |
[Primary non-Hodgkin's lymphoma of the paranasal sinuses: a report of 14 cases].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 2007 |
[CEOP regimen in the treatment for non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Child; Combined M | 2007 |
Relationship between the response to treatment and the prognosis of patients with aggressive lymphomas treated with chemotherapy followed by involved-field radiotherapy: radiographic assessment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2008 |
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Topics: Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclo | 2008 |
Primary T-cell lymphoma of the thyroid: case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Gen | 2008 |
Ocular involvement in nasal natural killer T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Eye; Fatal Outcome; F | 2009 |
The primary role of the otolaryngologist in managing pediatric sinonasal malignancies: an extranodal NK/T-cell lymphoma originating from the inferior turbinate mucosa of the nasal cavity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Female; Follow | 2008 |
Visual hallucinations following treatment with vincristine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin | 1994 |
[Non-Hodgkin's lymphoma with primary localization in the bladder and prostate region. Description of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hematuria; Humans; Ly | 1995 |
[T-cell lymphoma under immunosuppressive treatment in minimal change glomerulopathy with nephrotic syndrome].
Topics: Adult; Chlorambucil; Cyclosporins; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell; Nephr | 1995 |
[Lymphomas of the skin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Combined Modality | 1993 |
Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphocytes; Lymphoma, B-Ce | 1995 |
Primary extranodal non-Hodgkin's lymphoma of the lung presenting with bilateral, patchy infiltrates dramatically improving after corticosteroid therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchiolitis Obliterans; Diagnosis, Differe | 1993 |
Distinctive features of idiopathic inflammatory myopathies in French Canadians.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoi | 1996 |
Renal manifestations of angiotrophic lymphoma: clinicopathological features.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cycl | 1997 |
CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette T | 1997 |
Neuropathy associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma.
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dox | 1998 |
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
Topics: Adolescent; Adult; Age Distribution; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cy | 1998 |
Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1998 |
Angiocentric T-cell lymphoma of the lung mimicking metastatic carcinoma. Case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic | 1998 |
Primary esophageal T cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Barium Sulfate; Combined Modality Therapy; Cyclophos | 1999 |
[Exophthalmos and blindness disclosing an ethmoidal-maxillary malignant non-Hodgkin's T-cell lymphoma. Apropos of a case].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormon | 1999 |
Anaphylactoid reaction to cyclophosphamide in a patient with T cell lymphoma and hemophagocytic syndrome.
Topics: Anaphylaxis; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cycl | 1999 |
Destructive midline palatal lesion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic | 2000 |
Non-Hodgkin's lymphoma presenting as anasarca: probably mediated by tumor necrosis factor alpha (TNF-alpha).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capillary Leak Syndrome; Cyclophosphamide; Cy | 2000 |
Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 7; Cyclop | 2000 |
Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Appendic | 2000 |
Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carm | 2000 |
A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 2001 |
Nasal natural killer cell lymphoma presenting as lethal midline granuloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Diagnosis | 2000 |
[Occurrence of angioimmunoblastic T-cell lymphoma six months after onset of Lyme disease].
Topics: Aged; Amoxicillin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hu | 2000 |
Celiac disease and diffuse T-cell lymphoma of the colon.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Celiac Disease; Colonic Neoplasms; C | 2001 |
Leukocytoclastic vasculitis with IgA deposits in angioimmunoblastic T cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Diagnosis, Differential; DNA Primers; Dox | 2001 |
Primary endometrial T-cell lymphoma. A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Endometrial Neoplasms | 2001 |
CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival | 2001 |
T-cell lymphoma in the parotid region after cardiac transplant: case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Heart Transpla | 2001 |
[Long-term results with MACOP-B and radiation therapy for aggressive lymphomas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; C | 2001 |
gamma/delta peripheral T-cell lymphoma of the breast diagnosed by fine-needle aspiration biopsy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cyclophosph | 2002 |
Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome).
Topics: Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Autoimmune Diseas | 2002 |
Natural killer-like T-cell lymphoma of the parotid in a patient infected with human immunodeficiency virus.
Topics: Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophospha | 2002 |
[T-cell rich B-cell lymphoma associated with hemophagocytic syndrome].
Topics: Adult; Agranulocytosis; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Bleom | 1992 |
Epstein-Barr virus-associated T-cell lymphoma of the maxillary sinus in a renal transplant recipient.
Topics: Adult; Antigens, Viral; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA-Bindin | 1992 |
Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclopho | 1991 |
Direct comparison of peripheral T-cell lymphomas with their B-cell counterpart.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; China; Cyclophosphamide; Dexamethasone; D | 1991 |
Modified CHOP in an aged patient with non-Hodgkin's lymphoma and probable extensive pulmonary involvement.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 1991 |
[Malignant T-cell neoplasia during treatment with azathioprine and prednisone after kidney transplantation].
Topics: Azathioprine; Humans; Kidney Transplantation; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Time | 1991 |